Clinical Trial Update: Study of N-Acetylcysteine in Acute Liver Failure (ALF) [Phase 4]

View source ↗

Summary

Phase 4 trial of N-Acetylcysteine in acute liver failure was terminated with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fulminant Hepatic Failure
• Liver Failure

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Acute Liver Failure, Fulminant Hepatic Failure | Phase 4 | Status: TERMINATED | Results posted: 2014-01-29